Mallinckrodt Q4 Profit Rises - Quick Facts

(RTTNews) - Mallinckrodt plc (MNK), a global specialty pharmaceutical and medical imaging business, reported that its fourth-quarter net income increased to $35.8 million or $0.62 per share, from $26.2 million or $0.45 per share, last year. Income per share from continuing operations was $0.58, compared to $0.47, prior year. Adjusted net income was $59.1 million or $1.02 per share, for the quarter.

On average, seven analysts polled by Thomson Reuters expected the company to report profit per share of $0.85 for the quarter. Analyts' estimates typically exclude special items.

Net sales rose to $552.2 million, from $513.1 million, last year. Analysts expected revenue of $572.57 million for the quarter.

The company expects its fiscal 2014 adjusted earnings per share in the range of $2.45 to $2.65. Total Mallinckrodt net sales are expected to be in the range of $2.15 billion to $2.25 billion. Analysts expect the company to report fiscal 2014 profit per share of $2.44 on revenue of $2.18 billion.